This is not the most recent version of the article. View current version (31 JUL 2013)

Intervention Protocol

Leukodepletion for patients undergoing heart valve surgery

  1. Augustine Tang2,
  2. Sally Spencer1,*,
  3. Espeed Khoshbin3

Editorial Group: Cochrane Heart Group

Published Online: 7 DEC 2011

Assessed as up-to-date: 20 JUN 2011

DOI: 10.1002/14651858.CD009507


How to Cite

Tang A, Spencer S, Khoshbin E. Leukodepletion for patients undergoing heart valve surgery (Protocol). Cochrane Database of Systematic Reviews 2011, Issue 12. Art. No.: CD009507. DOI: 10.1002/14651858.CD009507.

Author Information

  1. 1

    Lancaster University, Faculty of Health and Medicine, Lancaster, Lancashire, UK

  2. 2

    Victoria Hospital, Department of Cardiothoracic Surgery, Lancashire Cardiac Centre, Blackpool, Lancashire, UK

  3. 3

    University Hospital of South Manchester, Cardiothoracic Surgery, Manchester, Cheshire, UK

*Sally Spencer, Faculty of Health and Medicine, Lancaster University, Bailrigg, Lancaster, Lancashire, LA1 4YD, UK. s.spencer1@lancaster.ac.uk.

Publication History

  1. Publication Status: New
  2. Published Online: 7 DEC 2011

SEARCH

This is not the most recent version of the article. View current version (31 JUL 2013)

 

Abstract

  1. Top of page
  2. Abstract

This is the protocol for a review and there is no abstract. The objectives are as follows:

To assess the beneficial and harmful effects of leukodepletion on clinical, patient-reported and economic outcomes in patients undergoing heart valve surgery.